Shalby Ltd

Shalby Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Shalby Ltd

₹ 181 -1.36%
05 Jun - close price
shalby.org BSE: 540797 NSE: SHALBY
About

Shalby Ltd is engaged in healthcare delivery space in India. It operates a chain of multi-specialty hospitals across India. The business of the company is to offer tertiary and quaternary healthcare services to patients in various areas of specialization such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, renal transplantations, etc.[1]
The company is the global leader in knee replacement surgery and one of the top Indian hospitals in joint replacement surgery.

Key Points

Business Segments
1) Healthcare Services (90% in H1 FY25 vs 96% in FY22): [1] [2] The company manages a network of 11 multispecialty tertiary hospitals and 5 orthopedic centers spanning 13 cities across India, with a total capacity of over 2,350 hospital beds, it provides services across 30+ specialties. Additionally, it operates 60 outpatient clinics domestically and 23 internationally. Between FY22 and FY24, segment revenue increased by 28%, driven by growth in in-patient numbers, including daycare services, and overall surgery count. [3] [4]

Website BSE NSE
  • Market Cap ₹ 1,951 Cr.
  • Current Price ₹ 181
  • High / Low ₹ 325 / 177
  • Stock P/E 23.3
  • Book Value ₹ 105
  • Dividend Yield 0.66 %
  • ROCE 12.1 %
  • ROE 7.63 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has a low return on equity of 8.59% over last 3 years.
  • Dividend payout has been low at 9.45% of profits over last 3 years
  • Working capital days have increased from 77.0 days to 147 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
148 177 178 176 177 211 217 195 206 233 212 221 207
120 138 139 141 147 167 165 152 168 182 177 178 176
Operating Profit 28 39 39 35 30 45 52 43 38 50 35 43 31
OPM % 19% 22% 22% 20% 17% 21% 24% 22% 19% 22% 17% 19% 15%
4 4 5 4 6 5 6 5 4 8 5 6 7
Interest 1 1 1 1 1 1 1 1 1 3 3 3 3
Depreciation 9 9 9 9 9 9 9 9 9 10 10 10 10
Profit before tax 23 33 34 29 26 40 47 38 33 46 28 36 26
Tax % 31% 35% 35% 33% 31% 35% 36% 36% 31% 34% 39% 42% 42%
16 21 22 19 18 26 30 25 23 30 17 21 15
EPS in Rs 1.45 1.99 2.02 1.78 1.70 2.42 2.81 2.29 2.09 2.82 1.61 1.93 1.39
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2014 Mar 2015 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
132 241 263 322 380 462 484 419 647 708 830 873
107 177 192 250 300 379 401 331 516 565 651 713
Operating Profit 25 64 70 73 80 84 83 88 131 143 179 159
OPM % 19% 27% 27% 23% 21% 18% 17% 21% 20% 20% 22% 18%
1 3 2 6 10 9 18 9 9 20 21 26
Interest 0 2 5 11 12 9 7 4 4 4 4 11
Depreciation 5 10 20 16 22 33 36 37 36 37 37 39
Profit before tax 21 56 47 52 55 51 57 55 100 121 158 136
Tax % 34% 26% 39% 42% 26% 37% 51% 23% 30% 33% 34% 38%
14 41 28 30 40 32 28 43 70 81 104 84
EPS in Rs 5.47 11.79 8.15 3.47 3.75 2.97 2.59 3.97 6.46 7.48 9.61 7.76
Dividend Payout % 0% 0% 0% 0% 0% 17% 19% 25% 15% 16% 12% 0%
Compounded Sales Growth
10 Years: 13%
5 Years: 13%
3 Years: 11%
TTM: 5%
Compounded Profit Growth
10 Years: 11%
5 Years: 25%
3 Years: 5%
TTM: -15%
Stock Price CAGR
10 Years: %
5 Years: 21%
3 Years: 16%
1 Year: -31%
Return on Equity
10 Years: %
5 Years: 8%
3 Years: 9%
Last Year: 8%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2014 Mar 2015 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 25 35 35 87 108 108 108 108 108 107 107 107
Reserves 23 111 137 171 657 686 706 742 799 863 955 1,027
0 37 98 325 114 71 62 44 41 34 121 110
19 32 77 99 96 91 105 119 139 163 192 226
Total Liabilities 67 215 347 682 975 956 981 1,012 1,087 1,167 1,376 1,470
31 105 144 312 647 689 670 658 628 603 599 579
CWIP 0 5 91 221 47 3 6 8 6 10 5 8
Investments 6 19 26 10 10 24 43 32 62 313 511 599
30 86 86 139 270 239 262 315 391 242 260 284
Total Assets 67 215 347 682 975 956 981 1,012 1,087 1,167 1,376 1,470

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2014 Mar 2015 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
7 71 15 46 57 77 101 165 140 149
-5 -157 -241 -0 -32 -52 -40 -172 -206 -101
-3 89 226 -51 -22 -28 -17 -38 72 -36
Net Cash Flow -1 3 -1 -6 3 -2 43 -46 6 12

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2014 Mar 2015 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 25 21 28 38 48 64 69 81 53 46 52 55
Inventory Days
Days Payable
Cash Conversion Cycle 25 21 28 38 48 64 69 81 53 46 52 55
Working Capital Days 16 41 -60 -28 0 61 73 87 82 41 43 147
ROCE % 48% 23% 9% 7% 7% 7% 12% 13% 14% 12%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
74.04% 74.04% 74.12% 74.12% 74.12% 74.12% 74.12% 74.24% 74.25% 74.25% 74.27% 74.27%
3.92% 3.78% 3.97% 3.92% 4.00% 4.11% 4.62% 4.88% 5.35% 5.37% 4.65% 4.54%
0.00% 0.28% 0.06% 0.00% 0.00% 0.00% 0.00% 0.00% 0.06% 0.09% 0.14% 0.18%
21.12% 20.97% 20.97% 21.09% 21.00% 20.90% 20.42% 20.13% 19.65% 19.59% 20.26% 20.33%
0.93% 0.93% 0.87% 0.87% 0.87% 0.87% 0.83% 0.76% 0.70% 0.69% 0.69% 0.69%
No. of Shareholders 54,66654,53752,77552,18152,58050,22549,49549,85849,31551,47952,32852,895

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls